Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ambroxol hydrochloride plus alpha-amylase for acute rhinopharyngitis and acute bronchitis in adults
2007-001702-24Phase 3Active
- Sponsor
- Laboratoire Top Pharm
- Start
- Sep 2007
- Modality
- Small Molecules, Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, single-arm trial of ambroxol and alpha-amylase in acute bronchitis, sponsored by Laboratoire Top Pharm. Primary endpoints: Improvement in cough, Improvement in pain and 1 more. Started Sep 2007; status: active.
02
Drugs
ambroxolalpha-amylase
03
Conditions
acute bronchitis
Beyond the preview
Go deeper on 2007-001702-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001702-24.